RAC Product Development & Registration

Question 1

What is the primary goal of Phase 1 clinical trials?

Accepted Answer

Assess safety and dosing

Answer

Phase 1 clinical trials are the first stage of testing a new drug in humans, typically involving a small group of healthy volunteers or patients with the target condition. The primary goal is to assess the drug's safety, determine a safe dosage range, and understand how the drug is metabolized and excreted (pharmacokinetics). Efficacy is not the main focus at this early stage.

Question 2

What does an NDA submission include?

Accepted Answer

Complete safety, efficacy, and manufacturing data

Answer

A New Drug Application (NDA) is a comprehensive submission to the FDA requesting approval to market a new drug in the U.S. It must include all data and information about the drug, including results from all clinical trials (safety and efficacy), detailed manufacturing processes, quality control information, and proposed labeling. The NDA demonstrates that the drug is safe and effective for its intended use.

Question 3

Which regulatory document is used to gain permission to ship a drug across state lines before approval?

Accepted Answer

Investigational New Drug (IND)

Answer

An Investigational New Drug (IND) application is the regulatory document submitted to the FDA to obtain permission to conduct clinical trials in humans. This approval allows the sponsor to ship the investigational drug across state lines for the purpose of these clinical investigations. Without an approved IND, interstate commerce of an unapproved drug for human testing is prohibited.

Question 4

Which phase of clinical trials focuses on therapeutic effectiveness?

Accepted Answer

Phase 2

Answer

Phase 2 clinical trials are designed to evaluate the drug's effectiveness for a specific indication in a larger group of patients, typically several hundred. This phase also continues to assess safety and determine the optimal dosage range. The primary focus is to gather preliminary data on whether the drug works as intended and to further characterize its side effects.

Question 5

What is the role of a Common Technical Document (CTD)?

Accepted Answer

To harmonize regulatory submissions

Answer

The Common Technical Document (CTD) is an internationally agreed-upon format for organizing applications to regulatory authorities for the registration of medicines. Its primary role is to harmonize the structure and content of regulatory submissions across different regions, such as the US, Europe, and Japan. This standardization streamlines the review process and reduces the burden on pharmaceutical companies.

(RAC) Regulatory Affairs Certification Practice Test

(RAC) Regulatory Affairs Certification Practice Test

RAC Product Development & Registration